DrugPatentWatch Database Preview
Litigation Details for Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)
» See Plans and Pricing
Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)
| Docket | Start Trial | Date Filed | 2015-08-05 |
| Court | District Court, D. Delaware | Date Terminated | 2018-04-24 |
| Cause | 35:0145 | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Parties | ACTAVIS LABORATORIES FL, INC.; ALVOGEN PINE BROOK INC.; ALVOGEN PINE BROOK LLC; GRUNENTHAL GMBH; PURDUE PHARMA L.P.; PURDUE PHARMACEUTICALS L.P.; THE P.F. LABORATORIES INC. | ||
| Patents | 6,011,020; 6,733,783; 8,114,383; 8,309,060; 8,361,499; 8,529,948; 8,551,520; 8,647,667; 8,808,740; 9,023,401; 9,056,052; 9,060,940; 9,084,816; 9,095,614; 9,095,615; 9,198,863; 9,205,056; 9,486,412; 9,486,413; 9,492,390; 9,492,391; 9,517,236; 9,545,380; 9,572,779; 9,572,804; 9,669,024; 9,675,610; 9,675,611; 9,750,703; 9,763,933; 9,775,809 | ||
| Attorneys | Aaron M. Nelson; Dominick T. Gattuso; Edward M. Mathias; Evan T. Lee; Gary E. Hood; Gasper J. LaRosa; Gita Srivastava; Graham L.W. Day; Jack B. Blumenfeld; James L. Higgins; Jason A. Wietjes; Jason G. Winchester; Jeffrey I.D. Lewis; Jenny Shum; Jeremy Lowe; John J. Normile; Joshua S. Reisberg; Kenneth S. Canfield; Khurram Naik; Lisamarie LoGiudice; Mark T. Deming; Matthew J. Becker; Megan Elizabeth Dellinger; Melanie K. Sharp; Michelle Wang; Nicholas J Doyle; Rebecca L. Clegg; Ricardo S. Camposanto; Robert M. Vrana; Rodger Dallery Smith , II; Sarah A. Geers; Stacie L. Ropka; Thomas G. Rohback | ||
| Firms | Axinn, Veltrop & Harkrider, LLP; Heyman Enerio Gattuso & Hirzel LLP; Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Purdue Pharma L.P. v. Alvogen Pine Brook LLC
The small molecule drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Purdue Pharma L.P. v. Alvogen Pine Brook LLC (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-04-18 | 175 | Hossein Omidian Regarding Invalidity of U.S. Patent Nos. 6,733,783; 8,361,499; 8,551,520; 8,647,667; 9,023,…2015 24 April 2018 1:15-cv-00687 830 Patent None District Court, D. Delaware | External link to document | |
| 2017-04-19 | 177 | Jacobs, Ph.D. Concerning Invalidity of U.S. Patent Nos. 6,733,783; 8,551,520; 8,647,667; 9,060,940; 9,205,…Mayersohn, Ph.D. Concerning Invalidity of U.S. Patent Nos. 6,733,783; 8,551,520; 8,647,667; 9,060,940; 9,205,…Muzzio, Ph.D. Concerning the Invalidity of U.S. Patent Nos. 8,529,948; 8,309,060; 9,084,816; 9,095,614…Ryu, Ph.D. Concerning the Indefiniteness of U.S. Patent Nos. 9,198,863 and 8,808,740 filed by Alvogen Pine…2015 24 April 2018 1:15-cv-00687 830 Patent None District Court, D. Delaware | External link to document | |
| 2017-05-10 | 178 | cannot be easily pulverized or crushed. Id. col. 6 11. 20-23. The specification goes on to explain that ….S. Patent Nos. 6,733,783 ("the '783 patent"), 8,361,499 ("the '499 patent"…948 patent"), 8,808,740 ("the '740 patent"), 9,056,052 ("the '052 patent"…8,551,520 ("the '520 patent"), 8,647,667 ("the '667 patent"), 9,023,401 ("…quot;the '401 patent), 8,309,060 (''the '060 patent"), 8,529,948 ("the '948 | External link to document | |
| 2015-10-13 | 18 | owner of U.S. Patent Nos. 6,733,783 (“the ‘783 patent”), 8,361,499 (“the ‘499 patent”), 8,551,520 (“…U.S. Patent No. 8,529,948 (“the ‘948 patent). The ‘783 patent, the ‘499 patent, the ‘520 patent, the …the ‘667 patent, the ‘401 patent, the ‘948 patent, the ‘740 patent, and the ‘060 patent, collectively, …(“the ‘520 patent”), 8,647,667 (“the ‘667 patent”), 9,023,401 (“the ‘401 patent”), and 8,808,740 (“the…740 patent”), and that it is an exclusive licensee of U.S. Patent No. 8,309,060 (“the ‘060 patent”) ( | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
